Albani, C, Blaser, G, Geyer, M, Schmutzer, G and Brähler, E (2010) Outpatient psychotherapy in Germany from the patient perspective. Part 1: health care situation. Psychotherapeut 55, 503–514.
Altmann, U, Thielemann, D, Zimmermann, A, Steffanowski, A, Bruckmeier, E, Pfaffinger, I, Fembacher, A and Strauss, B (2018) Outpatient psychotherapy improves symptoms and reduces health care costs in regularly and prematurely terminated therapies. Frontiers in Psychology 9, 748.
Andersson, G and Titov, N (2014) Advantages and limitations of internet-based interventions for common mental disorders. World Psychiatry 13, 4–11.
Andrews, G, Basu, A, Cuijpers, P, Craske, MG, McEvoy, P, English, CL and Newby, JM (2018) Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: an updated meta-analysis. Journal of Anxiety Disorders 55, 70–78.
Barlow, J, Schrader McMillan, A, Kirkpatrick, S, Ghate, D, Barnes, J and Smith, M (2010) Health-led interventions in the early years to enhance infant and maternal mental health: a review of reviews. Child and Adolescent Mental Health 15, 178–185.
Barth, M, Kriston, L, Klostermann, S, Barbui, C, Cipriani, A and Linde, K (2016) Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials. British Journal of Psychiatry 208, 114–119.
Baskin, TW, Tierney, SC, Minami, T and Wampold, BE (2003) Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls. Journal of Consulting and Clinical Psychology 71, 973–979.
Boutron, I, Moher, D, Altman, DG, Schulz, KF and Ravaud, P (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 148, 295–309.
Carpenter, JK, Andrews, LA, Witcraft, SM, Powers, MB, Smits, JAJ and Hofmann, SG (2018) Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depression and Anxiety 35, 502–514.
Chalmers, I, Bracken, MB, Djulbegovic, B, Garattini, S, Grant, J, Gulmezoglu, AM, Howells, DW, Ioannidis, JPA and Oliver, S (2014) How to increase value and reduce waste when research priorities are set. Lancet 383, 156–165.
Cipriani, A, Reid, K, Young, AH, Macritchie, K and Geddes, J (2013) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews 10, CD003196.
Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ, Ogawa, Y, Leucht, S, Ruhe, HG, Turner, EH, Higgins, JPT, Egger, M, Takeshima, N, Hayasaka, Y, Imai, H, Shinohara, K, Tajika, A, Ioannidis, JPA and Geddes, JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357–1366.
Clark, DM (2018) Realizing the mass public benefit of evidence-based psychological therapies: the IAPT Program. Annual Review of Clinical Psychology 14, 159–183.
Clark, DM, Canvin, L, Green, J, Layard, R, Pilling, S and Janecka, M (2018) Transparency about the outcomes of mental health services (IAPT approach): an analysis of public data. Lancet 391, 679–686.
Cloitre, M (2015) The ‘one size fits all’ approach to trauma treatment: should we be satisfied? European Journal of Psychotraumatology 6, 27344.
Cox, J, Martinez, R and Southam-Gerow, M (2019) Treatment integrity in psychotherapy research and implications for the delivery of quality mental health services. Journal of Consulting and Clinical Psychology 87, 221–233.
Cristea, IA, Gentili, C, Cotet, CD, Palomba, D, Barbui, C and Cuijpers, P (2017a) Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry 74, 319–328.
Cristea, IA, Stefan, S, Karyotaki, E, David, D, Hollon, SD and Cuijpers, P (2017b) The effects of cognitive behavioral therapy are not systematically falling: a revision of Johnsen and Friborg (2015). Psychological Bulletin 143, 326–340.
Cuijpers, P, Karyotaki, E, Weitz, E, Andersson, G, Hollon, SD and van Straten, A (2014) The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. Journal of Affective Disorders 159, 118–126.
Cuijpers, P, Cristea, IA, Karyotaki, E, Reijnders, M and Huibers, MHJ (2016) How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 15, 245–258.
Cuijpers, P, Karyotaki, E, Reijnders, M and Ebert, DD (2019) Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression. Epidemiology and Psychiatric Sciences 28, 21–30.
Curtiss, J, Andrews, L, Davis, M, Smits, J and Hofmann, SG (2017) A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators. Expert Opinion on Pharmacotherapy 18, 243–251.
Dakin, E and Arean, P (2013) Patient perspectives on the benefits of psychotherapy for late-life depression. American Journal of Geriatric Psychiatry 21, 155–163.
Driessen, E, Hollon, SD, Bockting, CL, Cuijpers, P and Turner, EH (2015) Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-funded trials. PLoS ONE 10, e0137864.
Eckshtain, D, Kuppens, S, Ugueto, A, Ng, MY, Vaughn-Coaxum, R, Corteselli, K and Weisz, JR (2019) Meta-analysis: 13-year follow-up of psychotherapy effects on youth depression. Journal of the American Academy of Child and Adolescent Psychiatry . doi: 10.1016/j.jaac.2019.04.002
Fava, G, Tomba, E and Sonino, N (2012) Clinimetrics: the science of clinical measurements. International Journal of Clinical Practice 66, 11–15.
Friborg, O and Johnsen, TJ (2017) The effect of cognitive-behavioral therapy as an antidepressive treatment is falling: reply to Ljotsson et al. (2017) and Cristea et al. (2017). Psychological Bulletin 143, 341–345.
Furukawa, TA, Cipriani, A, Atkinson, LZ, Leucht, S, Ogawa, Y, Takeshima, N, Hayasaka, Y, Chaimani, A and Salanti, G (2016) Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. The Lancet. Psychiatry 3, 1059–1066.
Glasziou, P, Meats, E, Heneghan, C and Shepperd, S (2008) What is missing from descriptions of treatment in trials and reviews? BMJ (Clinical Research Ed.) 336, 1472–1474.
Glasziou, P, Macleod, M, Chalmers, I, Ioannidis, JPA, Al-Shahi Salman, R and Chan, AW (2014) Research: increasing value, reducing waste – authors’ reply. Lancet 383, 1126–1127.
Gomez, AF, Barthel, AL and Hofmann, SG (2018) Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opinion on Pharmacotherapy 19, 883–894.
Guidi, J, Brakemeier, E, Bockting, C, Cosci, F, Cuijpers, P, Jarrett, R, Linden, M, Marks, I, Peretti, C, Rafanelli, C, Rief, W, Schneider, S, Schnyder, U, Sensky, T, Tomba, E, Vazquez, C, Vieta, E, Zipfel, S, Wright, J and Fava, G (2017) Methodological recommendations for trials of psychological interventions. Psychotherapy and Psychosomatics 87, 276–284.
Gustavsson, A, Svensson, M, Jacobi, F, Allgulander, C, Alonso, J, Beghi, E, Dodel, R, Ekman, M, Faravelli, C, Fratiglioni, L, Gannon, B, Hilton Jones, D, Jennum, P, Jordanova, A, Jönsson, L, Karampampa, K, Knapp, M, Kobelt, G, Kurth, T, Lieb, R, Linde, M, Ljungcrantz, C, Maercker, A, Melin, B, Moscarelli, M, Musayev, A, Norwood, F, Preisig, M, Pugliatti, M, Rehm, J, Salvador-Carulla, L, Schlehofer, B, Simon, R, Steinhausen, H-C, Stovner, LJ, Vallat, J-M, Van den Bergh, P, van Os, J, Vos, P, Xu, W, Wittchen, H-U, Jönsson, B and Olesen, J (2011) Costs of disorders of the brain in Europe 2010. European Neuropsychopharmacology 21, 718–779.
Heeren, A, Mogoase, C, Philippot, P and McNally, RJ (2015) Attention bias modification for social anxiety: a systematic review and meta-analysis. Clinical Psychology Review 40, 76–90.
Herpertz, S, Herzog, W and Taubner, S (2016) Prevention of mental and psychosomatic disorders in occupational and training settings. Mental Health & Prevention 4, 1–2.
Hoffmann, TC, Erueti, C and Glasziou, P (2013) Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ (Clinical Research Ed.) 347, f3755.
Hoffmann, TC, Glasziou, P, Boutron, I, Milne, R, Perera, R, Moher, D, Altman, DG, Barbour, V, Macdonald, H, Johnston, M, Lamb, SE, Dixon-Woods, M, McCulloch, P, Wyatt, JC, Chan, AW and Michie, S (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical Research Ed.) 348, g1687.
Hoffmann, TC, Walker, MF, Langhorne, P, Eames, S, Thomas, E and Glasziou, P (2015) What's in a name? The challenge of describing interventions in systematic reviews: analysis of a random sample of reviews of non-pharmacological stroke interventions. BMJ Open 5, e009051.
Hoffmann, T, Oxman, A, Ioannidis, JPA, Moher, D, Lasserson, T, Tovey, D, Stein, K, Sutcliffe, K, Ravaud, P, Altman, D, Perera, R and Glasziou, P (2017) Enhancing the usability of systematic reviews by improving the consideration and description of intervention. BMJ (Clinical Research Ed.) 358, j2998.
Huhn, M, Tardy, M, Spineli, LM, Kissling, W, Forstl, H, Pitschel-Walz, G, Leucht, C, Samara, M, Dold, M, Davis, JM and Leucht, S (2014) Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 71, 706–715.
Imai, H, Tajika, A, Chen, P, Pompoli, A and Furukawa, TA (2016) Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews 10, CD011170.
Ioannidis, JPA (2005) Why most published research findings are false. PLoS Medicine 2, e124.
Ioannidis, JPA (2008) Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philosophy, Ethics, and Humanities in Medicine 3, 14.
Jauhar, S, McKenna, PJ, Radua, J, Fung, E, Salvador, R and Laws, KR (2014) Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. British Journal of Psychiatry 204, 20–29.
Johnsen, TJ and Friborg, O (2015) The effects of cognitive behavioral therapy as an anti-depressive treatment is falling: a meta-analysis. Psychological Bulletin 141, 747–768.
Kopta, S, Howard, K, Lowry, J and Beutler, L (1994) Patterns of symptomatic recovery in psychotherapy. Journal of Consulting and Clinical Psychology 62, 1009–1016.
Kraemer, HC and Kupfer, DJ (2006) Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry 59, 990–996.
Lambert, M (2013) The efficacy and effectiveness of psychotherapy. In Lambert, M. (ed.), Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. New York: Wiley, pp. 169–218.
Leichsenring, F and Leweke, F (2017) Social anxiety disorder. New England Journal of Medicine 376, 2255–2264.
Leichsenring, F, Abbass, AA, Hilsenroth, MJ, Leweke, F, Luyten, P, Keefe, JR, Midgley, N, Rabung, S, Salzer, S and Steinert, C (2017) Biases in research: risk factors for non-replicability in psychotherapy and pharmacotherapy research. Psychological Medicine 47, 1000–1011.
Leichsenring, F, Sarrar, L and Steinert, C (2019) Drop-outs in psychotherapy: a change of perspective. World Psychiatry 18, 32–33.
Leucht, S (2014) Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application. Journal of Clinical Psychiatry 75(Suppl. 1), 8–14.
Leucht, S, Leucht, C, Huhn, M, Chaimani, A, Mavridis, D, Helfer, B, Samara, M, Rabaioli, M, Bacher, S, Cipriani, A, Geddes, JR, Salanti, G and Davis, JM (2017) Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. American Journal of Psychiatry 174, 927–942.
Li, X, Zhu, L, Su, Y and Fang, S (2017) Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: a meta-analysis. PLoS ONE 12, e0185865.
Linden, M and Schermuly-Haupt, ML (2014) Definition, assessment and rate of psychotherapy side effects. World Psychiatry 13, 306–309.
Liu, H, Li, X, Han, B and Liu, X (2017) Effects of cognitive bias modification on social anxiety: a meta-analysis. PLoS ONE 12, e0175107.
Loerinc, AG, Meuret, AE, Twohig, MP, Rosenfield, D, Bluett, EJ and Craske, MG (2015) Response rates for CBT for anxiety disorders: need for standardized criteria. Clinical Psychology Review 42, 72–82.
Lorsch, JR (2015) Maximizing the return on taxpayers’ investments in fundamental biomedical research. Molecular Biology of the Cell 26, 1578–1582.
Markowitz, JC and Milrod, BL (2015) What to do when a psychotherapy fails. The Lancet. Psychiatry 2, 186–190.
McDaid, D and Park, A (2011) Investing in mental health and well-being: findings from the DataPrev project. Health Promotion International 26 (Suppl 1), i108–i139.
McKay, KM, Imel, ZE and Wampold, BE (2006) Psychiatrist effects in the psychopharmacological treatment of depression. Journal of Affective Disorders 92, 287–290.
Midgley, N, Besser, SJ, Fearon, P, Wyatt, S, Byford, S and Wellsted, D (2019) The Herts and Minds study: feasibility of a randomised controlled trial of mentalization-based treatment versus usual care to support the wellbeing of children in foster care. BMC Psychiatry 19, 215.
MQ (2015) .
Munafò, MR, Nosek, BA, Bishop, DV, Button, KS, Chambers, CD, Percie du Sert, N, Simonsohn, U, Wagenmakers, EJ, Ware, J and Ioannidis, JPA (2017) A manifesto for reproducible science. Nature Human Behavior 1, 0021.
Nahum-Shani, I, Qian, M, Almirall, D, Pelham, WE, Gnagy, B, Fabiano, GA, Waxmonsky, JG, Yu, J and Murphy, SA (2012) Experimental design and primary data analysis methods for comparing adaptive interventions. Psychological Methods 17, 457–477.
Nicholson, JM and Ioannidis, JPA (2012) Research grants: conform and be funded. Nature 492, 34–36.
Nutt, D (2014) Help luck along to find psychiatric medicines. Nature 515, 165.
Open Science Collaboration (2015) Estimating the reproducibility of psychological science. Science 349, aac4716.
Öst, L-G (2008) Cognitive behavior therapy for anxiety disorders: 40 years of progress. Nordic Journal of Psychiatry 47, 5–10.
Patel, V, Saxena, S, Lund, C, Thornicroft, G, Baingana, F, Bolton, P, Chisholm, D, Collins, PY, Cooper, JL, Eaton, J, Herrman, H, Herzallah, MM, Huang, Y, Jordans, MJD, Kleinman, A, Medina-Mora, ME, Morgan, E, Niaz, U, Omigbodun, O, Prince, M, Rahman, A, Saraceno, B, Sarkar, BK, De Silva, M, Singh, I, Stein, DJ, Sunkel, C and UnÜtzer, J (2018) The Lancet commission on global mental health and sustainable development. Lancet 392, 1553–1598.
Rousmaniere, T, Abbass, AA and Frederickson, J (2014) New developments in technology-assisted supervision and training: a practical overview. Journal of Clinical Psychology 70, 1082–1093.
Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, Niederehe, G, Thase, ME, Lavori, PW, Lebowitz, BD, McGrath, PJ, Rosenbaum, JF, Sackeim, HA, Kupfer, DJ, Luther, J and Fava, M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163, 1905–1917.
Sakaluk, JK, Kilshaw, RE, Williams, AJ and Rhyner, KT (2019) Evaluating the evidential value of empirically supported psychological treatments (ESTs): a meta-scientific review. Journal of Abnormal Psychology 128, 500–509.
Schalkwijk, S, Undurraga, J, Tondo, L and Baldessarini, RJ (2014) Declining efficacy in controlled trials of antidepressants: effects of placebo dropout. International Journal of Neuropsychopharmacology 17, 1343–1352.
Schroter, S, Glasziou, P and Heneghan, C (2012) Quality of descriptions of treatments: a review of published randomised controlled trials. BMJ Open 2, e001978.
Sherman, RE, Anderson, SA, Dal Pan, GJ, Gray, GW, Gross, T, Hunter, NL, LaVange, L, Marinac-Dabic, D, Marks, PW, Robb, MA, Shuren, J, Temple, R, Woodcock, J, Yue, LQ and Califf, RM (2016) Real-world evidence – what is it and what can it tell us? New England Journal of Medicine 375, 2293–2297.
Shimokawa, K, Lambert, MJ and Smart, DW (2010) Enhancing treatment outcome of patients at risk of treatment failure: meta-analytic and mega-analytic review of a psychotherapy quality assurance system. Journal of Consulting and Clinical Psychology 78, 298–311.
Smith, K (2011) Trillion-dollar brain drain-enormous costs of mental health problems in Europe not matched by research investment. Nature 478, 15.
Springer, KS, Levy, HC and Tolin, DF (2018) Remission in CBT for adult anxiety disorders: a meta-analysis. Clinical Psychology Review 61, 1–8.
Steinert, C, Kruse, J and Leichsenring, F (2016) Long-term outcome and non-response in psychotherapy: are we short-sighted. Psychotherapy and Psychosomatics 85, 235–237.
Swift, J, Greenberg, R, Tompkins, K and Parkin, S (2017) Treatment refusal and premature termination in psychotherapy, pharmacotherapy, and their combination: a meta-analysis of head-to-head comparisons. Psychotherapy (Chic) 54, 47–57.
Tajika, A, Ogawa, Y, Takeshima, N, Hayasaka, Y and Furukawa, TA (2015) Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up. British Journal of Psychiatry 207, 357–362.
Taubner, S, Wolter, S and Rabung, S (2015) Effectiveness of early-intervention programs in German-speaking countries – a meta-analysis. Mental Health & Prevention 3, 69–78.
Thase, ME (2014) Large-scale study suggests specific indicators for combined cognitive therapy and pharmacotherapy in major depressive disorder. JAMA Psychiatry 71, 1101–1102.
Tolin, D, McKay, D, Forman, EM, Klonsky, ED and Thombs, BD (2015) Empirically supported treatments: recommendations for a new model. Clinical Psychology: Science and Practice 22, 317–338.
van Dessel, N, den Boeft, M, van der Wouden, JC, Kleinstauber, M, Leone, SS, Terluin, B, Numans, ME, van der Horst, HE and van Marwijk, H (2014) Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews 11, CD011142.
van Os, J, Guloksuz, S, Vijn, TW, Hafkenscheid, A and Delespaul, P (2019) The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: time for change? World Psychiatry 18, 88–96.
Vigo, D, Thornicroft, G and Atun, R (2016) Estimating the true global burden of mental illness. The Lancet. Psychiatry 3, 171–178.
Wampold, BE and Imel, ZE (2015) The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work. New York: Routledge.
Watts, SE, Turnell, A, Kladnitski, N, Newby, JM and Andrews, G (2015) Treatment-as-usual (TAU) is anything but usual: a meta-analysis of CBT versus TAU for anxiety and depression. Journal of Affective Disorders 175, 152–167.
Webb, CA, deRubeis, RJ and Barber, J (2010) Therapist adherence/competence and treatment outcome: a meta-analytic review. Journal of Consulting and Clinical Psychology 78, 200–211.
Weisz, JR, Jensen-Doss, A and Hawley, KM (2006) Evidence-based youth psychotherapies versus usual clinical care: a meta-analysis of direct comparisons. American Psychologist 61, 671–689.
Weisz, JR, Kuppens, S, Eckshtain, D, Ugueto, AM, Hawley, KM and Jensen-Doss, A (2013) Performance of evidence-based youth psychotherapies compared with usual clinical care: a multilevel meta-analysis. JAMA Psychiatry 70, 750–761.
Weisz, JR, Kuppens, S, Ng, MY, Eckshtain, D, Ugueto, AM, Vaughn-Coaxum, R, Jensen-Doss, A, Hawley, KM, Krumholz Marchette, LS, Chu, BC, Weersing, VR and Fordwood, SR (2017) What five decades of research tells us about the effects of youth psychological therapy: a multilevel meta-analysis and implications for science and practice. American Psychologist 72, 79–117.
Weisz, JR, Kuppens, S, Ng, MY, Vaughn-Coaxum, RA, Ugueto, AM, Eckshtain, D and Corteselli, KA (2019) Are psychotherapies for young people growing stronger? Tracking trends over time for youth anxiety, depression, attention-deficit/hyperactivity disorder, and conduct problems. Perspectives on Psychological Science 14, 216–237.
Williams, T, Hattingh, CJ, Kariuki, CM, Tromp, SA, van Balkom, AJ, Ipser, JC and Stein, DJ (2017) Pharmacotherapy for social anxiety disorder (SAnD). Cochrane Database of Systematic Reviews 10, CD001206.